Insider Selling: Outset Medical, Inc. (NASDAQ:OM) SVP Sells $12,158.91 in Stock

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 15,011 shares of Outset Medical stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $0.81, for a total value of $12,158.91. Following the sale, the senior vice president now owns 222,291 shares in the company, valued at $180,055.71. This represents a 6.33 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Marc Nash also recently made the following trade(s):

• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $1,100.00.

Outset Medical Stock Down 6.1 %

Shares of Outset Medical stock opened at $0.76 on Thursday. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. The stock has a market capitalization of $40.06 million, a price-to-earnings ratio of -0.28 and a beta of 2.05. Outset Medical, Inc. has a twelve month low of $0.44 and a twelve month high of $5.22. The business’s 50 day simple moving average is $1.01 and its 200-day simple moving average is $1.39.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reissued a “sector perform” rating and issued a $3.00 price objective on shares of Outset Medical in a report on Tuesday, January 7th.

Institutional Trading of Outset Medical

Large investors have recently modified their holdings of the company. GSA Capital Partners LLP increased its position in Outset Medical by 924.7% in the 3rd quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after acquiring an additional 1,003,135 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Outset Medical by 118.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock worth $5,925,000 after purchasing an additional 834,663 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Outset Medical by 58.8% during the second quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock valued at $7,480,000 after purchasing an additional 719,412 shares during the period. Marshall Wace LLP raised its stake in shares of Outset Medical by 487.8% during the second quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock valued at $1,210,000 after purchasing an additional 260,740 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in Outset Medical in the second quarter worth about $827,000.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.